Shenzhen Salubris Pharmaceuticals

Shenzhen Salubris Pharmaceuticals

World Rank (Jan-05-2024)
2,903
Market Cap (Jan-05-2024)
5.028 Billion USD
World Rank (Jul-30-2023)
2,838
Market Cap (Jul-30-2023)
5.247 Billion USD
World Rank (Jan-07-2022)
3,506
Market Cap (Jan-07-2022)
4.603 Billion USD
World Rank (Jan-01-2021)
3,177
Market Cap (Jan-01-2021)
4.536 Billion USD
Company Rank in Country in 2023
Rank in China in July-2023 is 427
Headquarters Country
China
Market Cap (Mar-08-2026)
8.50
Employee Count
3,454
Employee Count as of Date
As on 2022
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
488 Million USD
Annual Operating Income in USD
89 Million USD
Annual Net Income in USD
89 Million USD
Annual Results for Period Ending
Dec-2022 ending period
Total Assets in USD
1,367 Million USD
Total Liabilities in USD
249 Million USD
Total Equity in USD
1,118 Million USD
Balance Sheet for Period Ending
Dec-2022 ending period
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Medical Equipment / Instruments
Company Website
SHENZHEN SALUBRIS PHARMACEUTICALS
Yahoo
Yahoo @ Shenzhen
Company Profile
Shenzhen Salubris Pharmaceuticals is a comprehensive pharmaceutical company that integrates pharmaceutical products research and development, production and business sales focuses on the therapeutic fields of cardiovascular, anti diabetic, antineoplastic and orthopedic as well as three mainlines of the high end chemical medicine, innovative biological medicines and medical apparatus and instruments. The company annual revenue is 416.07 million USD and 4,270 employees as on 2020. The headquarters is in China.
Stock Exchange
Shenzhen
Company SubCategory
Top Healthcare Companies in China

Share